Skip to main content
. 2017 Jun 7;152(8):e171505. doi: 10.1001/jamasurg.2017.1505

Table 4. Clinical Outcomes and Intraoperative Serious Events.

Variable Overall
(N = 390)
Intervention
(n = 189)
Placebo
(n = 201)
P Value
Delirium, No. (%)
Postoperative delirium 46 (11.8) 23 (12.2) 23 (11.4) .94
PACU delirium 14 (3.6) 6 (3.2) 8 (4.0)
Both 9 (2.3) 5 (2.6) 4 (2.0)
None 321 (82.3) 155 (82.0) 166 (82.6)
Intraoperative bradycardia, No. (%)
Requiring treatment 55 (14.1) 35 (18.5) 20 (10.0) .06
Requiring interruption of the drug 4 (1.0) 2 (1.1) 2 (1.0)
Resolved spontaneously 87 (22.3) 45 (23.8) 42 (20.9)
Did not occur 244 (62.6) 107 (56.6) 137 (68.2)
Intraoperative hypotension, No. (%)
Requiring treatment 150 (38.5) 81 (42.9) 69 (34.3) .36
Requiring interruption of the drug 8 (2.1) 3 (1.6) 5 (2.5)
Resolved spontaneously 39 (10.0) 18 (9.5) 21 (10.4)
Did not occur 193 (49.5) 87 (46.0) 106 (52.7)
Intraoperative hypertension, No. (%)
Requiring treatment 62 (15.9) 26 (13.8) 36 (17.9) .10
Requiring interruption of the drug 1 (0.3) 0 1 (0.5)
Resolved spontaneously 47 (12.1) 17 (9.0) 30 (14.9)
Did not occur 280 (71.8) 146 (77.2) 134 (66.7)
Death, No. (%) 4 (1.0) 1 (0.5) 3 (1.5) .35
Serious adverse event, No. (%) 22 (5.6) 13 (6.9) 9 (4.5) .30
Length of stay, median (IQR), d 4.0 (3.0-6.0) 4.0 (3.0-6.0) 4.0 (3.0-6.0) .27

Abbreviations: IQR, interquartile range; PACU, postanesthesia care unit.